Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Sarah L Sheridan, Katie Frith, Thomas L Snelling, Keith Grimwood, Peter B McIntyre & Stephen B Lambert. (2014) Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines 13:9, pages 1081-1106.
Read now
Read now
Arno AJ van der Ark, Daniela F Hozbor, Claire JP Boog, Bernard Metz, Germie PJM van den Dobbelsteen & Cécile ACM van Els. (2012) Resurgence of pertussis calls for re-evaluation of pertussis animal models. Expert Review of Vaccines 11:9, pages 1121-1137.
Read now
Read now
Jan T Poolman, Hans Hallander & Scott A Halperin. (2011) Pertussis vaccines: where to now?. Expert Review of Vaccines 10:11, pages 1497-1500.
Read now
Read now
Articles from other publishers (51)
Xuanxuan Nian, Hongbo Liu, Mengyao Cai, Kai Duan & Xiaoming Yang. (2023) Coping Strategies for Pertussis Resurgence. Vaccines 11:5, pages 889.
Crossref
Crossref
Arash Saeidpour, Shweta Bansal & Pejman Rohani. (2022) Dissecting recurrent waves of pertussis across the boroughs of London. PLOS Computational Biology 18:4, pages e1009898.
Crossref
Crossref
Natalie Ring, Heather Davies, Julie Morgan, Maithreyi Sundaresan, Audrey Tiong, Andrew Preston & Stefan Bagby. (2022) Comparative genomics of Bordetella pertussis isolates from New Zealand, a country with an uncommonly high incidence of whooping cough. Microbial Genomics 8:1.
Crossref
Crossref
Kateřina Fabiánová. (2021) PERTUSSIS - RE-EMERGIGNG DISEASE. Profese online 14:2, pages 14-21.
Crossref
Crossref
Shuang Wu, Qinghua Hu, Chao Yang, Haijian Zhou, Hongyu Chen, Yanwei Zhang, Min Jiang, Yuxiang He & Xiaolu Shi. (2021) Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China. Annals of Clinical Microbiology and Antimicrobials 20:1.
Crossref
Crossref
Diana Keizner, Shakiba Ghaffari, Samaneh Beheshti, Elena Newman, David Tulumello, Marina Kirkitadze & Michael Leach. (2021) Quantitative microcapillary electrophoresis immunoassay (mCE IA) for end-to-end analysis of pertactin within in-process samples and Quadracel® vaccine. Journal of Pharmaceutical and Biomedical Analysis 204, pages 114284.
Crossref
Crossref
Shweta Alai, Vikas C. Ghattargi, Manish Gautam, Krunal Patel, Shrikant P. Pawar, Dhiraj P. Dhotre, Umesh Shaligram & Sunil Gairola. (2020) Comparative genomics of whole-cell pertussis vaccine strains from India. BMC Genomics 21:1.
Crossref
Crossref
Sophia Häfner. (2020) Streptococcal oddity. Microbes and Infection 22:9, pages 392-396.
Crossref
Crossref
Lisa Szymkowicz, Derek J. Wilson & D. Andrew James. (2020) Development of a targeted nanoLC-MS/MS method for quantitation of residual toxins from Bordetella pertussis. Journal of Pharmaceutical and Biomedical Analysis 188, pages 113395.
Crossref
Crossref
Tadatsugu Imamura, Kensuke Shoji, Naoko Kono, Mitsuru Kubota, Nao Nishimura, Akira Ishiguro & Isao Miyairi. (2020) Allele frequencies of Bordetella pertussis virulence-associated genes identified from pediatric patients with severe respiratory infections. Journal of Infection and Chemotherapy 26:7, pages 765-768.
Crossref
Crossref
Vajihe Sadat Nikbin, Malihe Keramati, Mojtaba Noofeli, Faranak Tayebzadeh, Bahram Kahali & Fereshteh Shahcheraghi. (2020) Engineering of an Iranian Bordetella pertussis strain producing inactive pertussis toxin. Journal of Medical Microbiology 69:1, pages 111-119.
Crossref
Crossref
Jens Möller, Max Kraner, Uwe Sonnewald, Vartul Sangal, Hannes Tittlbach, Julia Winkler, Thomas H. Winkler, Vyacheslav Melnikov, Roland Lang, Andreas Sing, Ana Luiza Mattos-Guaraldi & Andreas Burkovski. (2019) Proteomics of diphtheria toxoid vaccines reveals multiple proteins that are immunogenic and may contribute to protection of humans against Corynebacterium diphtheriae. Vaccine 37:23, pages 3061-3070.
Crossref
Crossref
Alex-Mikael Barkoff & Qiushui He. 2019. Pertussis Infection and Vaccines. Pertussis Infection and Vaccines
19
33
.
Ying Chen, Zhenzhen Wang, Yingxun Liu, Xin Wang, Ying Li, Ping Ma, Bing Gu & Hongchun Li. (2018) Recent advances in rapid pathogen detection method based on biosensors. European Journal of Clinical Microbiology & Infectious Diseases 37:6, pages 1021-1037.
Crossref
Crossref
David A. Kennedy & Andrew F. Read. (2017) Why does drug resistance readily evolve but vaccine resistance does not?. Proceedings of the Royal Society B: Biological Sciences 284:1851, pages 20162562.
Crossref
Crossref
S. Esposito & N. Principi. (2016) Immunization against pertussis in adolescents and adults. Clinical Microbiology and Infection 22, pages S89-S95.
Crossref
Crossref
Katie L. Sealey, Thomas Belcher & Andrew Preston. (2016) Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Infection, Genetics and Evolution 40, pages 136-143.
Crossref
Crossref
Azadeh Safarchi, Sophie Octavia, Sunny Z. Wu, Sandeep Kaur, Vitali Sintchenko, Gwendolyn L. Gilbert, Nicholas Wood, Peter McIntyre, Helen Marshall, Anthony D. Keil & Ruiting Lan. (2016) Genomic dissection of Australian Bordetella pertussis isolates from the 2008–2012 epidemic. Journal of Infection 72:4, pages 468-477.
Crossref
Crossref
Katie L. Sealey, Simon R. Harris, Norman K. Fry, Laurence D. Hurst, Andrew R. Gorringe, Julian Parkhill & Andrew Preston. (2015) Genomic Analysis of Isolates From the United Kingdom 2012 Pertussis Outbreak Reveals That Vaccine Antigen Genes Are Unusually Fast Evolving. Journal of Infectious Diseases 212:2, pages 294-301.
Crossref
Crossref
Maria A. Riolo & Pejman Rohani. (2015) Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proceedings of the National Academy of Sciences 112:5.
Crossref
Crossref
Amy L. Leber. (2014) Pertussis. Clinics in Laboratory Medicine 34:2, pages 237-255.
Crossref
Crossref
Kerrie Vaughan, Emily Seymour, Bjoern Peters & Alessandro Sette. (2014) Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Human Immunology 75:5, pages 440-451.
Crossref
Crossref
Helen E. Quinn, Thomas L. Snelling, Kristine K. Macartney & Peter B. McIntyre. (2014) Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants. Pediatrics 133:3, pages e513-e519.
Crossref
Crossref
Hans Hallander, Abdolreza Advani, Frances Alexander, Lennart Gustafsson, Margaretha Ljungman, Catherine Pratt, Ian Hall & Andrew R. Gorringe. (2014) Antibody Responses to Bordetella pertussis Fim2 or Fim3 following Immunization with a Whole-Cell, Two-Component, or Five-Component Acellular Pertussis Vaccine and following Pertussis Disease in Children in Sweden in 1997 and 2007. Clinical and Vaccine Immunology 21:2, pages 165-173.
Crossref
Crossref
Nicola Principi & Susanna Esposito. (2013) Adolescents and vaccines in the western world. Vaccine 31:46, pages 5366-5374.
Crossref
Crossref
Jesús J. Gil-Tomás, Javier Colomina-Rodríguez, Olalla Martínez-Macías, María Borrás-Máñez & Antonio Guerrero-Espejo. (2013) Situación de la tos ferina en la Comunidad Valenciana: ¿asistimos a una reactivación epidémica?. Enfermedades Infecciosas y Microbiología Clínica 31:9, pages 590-594.
Crossref
Crossref
Jeeson C. Unni & S. Sachidananda Kamath. (2013) ARSH 10: Adolescent Immunization Revisited. The Indian Journal of Pediatrics 80:S2, pages 244-247.
Crossref
Crossref
Yusuke Miyaji, Nao Otsuka, Hiromi Toyoizumi-Ajisaka, Keigo Shibayama & Kazunari Kamachi. (2013) Genetic Analysis of Bordetella pertussis Isolates from the 2008–2010 Pertussis Epidemic in Japan. PLoS ONE 8:10, pages e77165.
Crossref
Crossref
Jimena Alvarez Hayes, Esteban Erben, Yanina Lamberti, Guido Principi, Fabricio Maschi, Miguel Ayala & Maria Eugenia Rodriguez. (2013) Bordetella pertussis iron regulated proteins as potential vaccine components. Vaccine 31:35, pages 3543-3548.
Crossref
Crossref
Gabriele Sorci, Stéphane Cornet & Bruno Faivre. (2013) Immunity and the emergence of virulent pathogens. Infection, Genetics and Evolution 16, pages 441-446.
Crossref
Crossref
Nicolas Hegerle, Lamya Rayat, Grégory Dore, Nora Zidane, Hugues Bedouelle & Nicole Guiso. (2013) In-vitro and in-vivo analysis of the production of the Bordetella type three secretion system effector A in Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Microbes and Infection 15:5, pages 399-408.
Crossref
Crossref
G. FABRICIUS, P. E. BERGERO, M. E. ORMAZABAL, A. L. MALTZ & D. F. HOZBOR. (2012) Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina. Epidemiology and Infection 141:4, pages 718-734.
Crossref
Crossref
Abdolreza Advani, Hans O. Hallander, Tine Dalby, Karen Angeliki Krogfelt, Nicole Guiso, Elisabeth Njamkepo, Carl Heinz Wirsing von Könnig, Marion Riffelmann, Frits R. Mooi, Per Sandven, Anna Lutyńska, Norman K. Fry, Jussi Mertsola & Qiushui He. (2013) Pulsed-Field Gel Electrophoresis Analysis of Bordetella pertussis Isolates Circulating in Europe from 1998 to 2009. Journal of Clinical Microbiology 51:2, pages 422-428.
Crossref
Crossref
Nathalie Mielcarek & Camille Locht. 2013. The Prokaryotes. The Prokaryotes
291
307
.
Frances Alexander, Mary Matheson, Norman K. Fry, Briony Labram & Andrew R. Gorringe. (2012) Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease. Clinical and Vaccine Immunology 19:11, pages 1776-1783.
Crossref
Crossref
Alex-Mikael Barkoff, Jussi Mertsola, Sophie Guillot, Nicole Guiso, Guy Berbers & Qiushui He. (2012) Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland. Clinical and Vaccine Immunology 19:10, pages 1703-1704.
Crossref
Crossref
Amber J. Schmidtke, Kathryn O. Boney, Stacey W. Martin, Tami H. Skoff, M. Lucia Tondella & Kathleen M. Tatti. (2012)
Population Diversity among
Bordetella pertussis
Isolates, United States, 1935–2009
. Emerging Infectious Diseases 18:8.
Crossref
Crossref
D. Bottero, M.E. Gaillard, L.A. Basile, M. Fritz & D.F. Hozbor. (2012) Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America. Journal of Applied Microbiology 112:6, pages 1266-1276.
Crossref
Crossref
Sophie Octavia, Vitali Sintchenko, Gwendolyn L. Gilbert, Andrew Lawrence, Anthony D. Keil, Geoff Hogg & Ruiting Lan. (2012) Newly Emerging Clones of Bordetella pertussis Carrying prn2 and ptxP3 Alleles Implicated in Australian Pertussis Epidemic in 2008–2010. The Journal of Infectious Diseases 205:8, pages 1220-1224.
Crossref
Crossref
Nao Otsuka, Hyun-Ja Han, Hiromi Toyoizumi-Ajisaka, Yukitsugu Nakamura, Yoshichika Arakawa, Keigo Shibayama & Kazunari Kamachi. (2012) Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan. PLoS ONE 7:2, pages e31985.
Crossref
Crossref
Jonathan M. Bock, Charles C. Burtis, David M. Poetker, Joel H. Blumin & Michael O. Frank. (2011)
Serum Immunoglobulin G Analysis to Establish a Delayed Diagnosis of Chronic Cough due to
Bordetella pertussis
. Otolaryngology–Head and Neck Surgery 146:1, pages 63-67.
Crossref
Crossref
Teemu Kallonen, Kirsi Gröndahl-Yli-Hannuksela, Annika Elomaa, Anna Lutyńska, Norman K. Fry, Jussi Mertsola & Qiushui He. (2011) Differences in the genomic content of Bordetella pertussis isolates before and after introduction of pertussis vaccines in four European countries. Infection, Genetics and Evolution 11:8, pages 2034-2042.
Crossref
Crossref
M. E. Gaillard, D. Bottero, C. E. Castuma, L. A. Basile & D. Hozbor. (2011) Laboratory Adaptation of Bordetella pertussis Is Associated with the Loss of Type Three Secretion System Functionality. Infection and Immunity 79:9, pages 3677-3682.
Crossref
Crossref
Jeri S. Burr, Tammara L. Jenkins, Rick Harrison, Kathleen Meert, K. J. S. Anand, John T. Berger, Jerry Zimmerman, Joseph Carcillo, J. Michael Dean, Christopher J. L. Newth, Douglas F. Willson, Ronald C. SandersJr.Jr., Murray M. Pollack, Eric Harvill & Carol E. Nicholson. (2011) The Collaborative Pediatric Critical Care Research Network Critical Pertussis Study: Collaborative research in pediatric critical care medicine*. Pediatric Critical Care Medicine 12:4, pages 387-392.
Crossref
Crossref
Ewa Mosiej, Ewa Augustynowicz, Monika Zawadka, Waldemar Dąbrowski & Anna Lutyńska. (2011) Strain Variation among Bordetella pertussis Isolates Circulating in Poland after 50 Years of Whole-Cell Pertussis Vaccine Use. Journal of Clinical Microbiology 49:4, pages 1452-1457.
Crossref
Crossref
Abdolreza Advani, Lennart Gustafsson, Christina Åhrén, Frits R. Mooi & Hans O Hallander. (2011) Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 29:18, pages 3438-3442.
Crossref
Crossref
Marieke J Bart, Marjolein van Gent, Han GJ van der Heide, Jos Boekhorst, Peter Hermans, Julian Parkhill & Frits R Mooi. (2010) Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics 11:1.
Crossref
Crossref
Natalia Kurova, Elisabeth Njamkepo, Delphine Brun, Galina Tseneva & Nicole Guiso. (2010) Monitoring of Bordetella isolates circulating in Saint Petersburg, Russia between 2001 and 2009. Research in Microbiology 161:10, pages 810-815.
Crossref
Crossref
Liu ZhangYinghua XuJianhong Zhao, Teemu Kallonen, Shenghui Cui, Yunqiang Xu, Qiming Hou, Fengxiang Li, Junzhi Wang, Qiushui He & Shumin Zhang. (2010)
Effect of Vaccination on
Bordetella pertussis
Strains, China
. Emerging Infectious Diseases 16:11, pages 1695-1701.
Crossref
Crossref
Matthew Hewitt & Brendan J. Canning. (2009) Coughing Precipitated by Bordetella pertussis Infection. Lung 188:S1, pages 73-79.
Crossref
Crossref
Yinghua Xu, Yaying Wang, Yajun Tan, Huajie Zhang, Lijie Wu, Lichan Wang, Qiming Hou & Shumin Zhang. (2009) Production and characterization of recombinant pertactin, fimbriae 2 and fimbriae 3 from Bordetella pertussis. BMC Microbiology 9:1.
Crossref
Crossref